Guatemala vs Iran: Cause of death, by non-communicable diseases, ages 15-59, female
Guatemala
54.7%
in 2021
Iran
54.9%
in 2021
Guatemala rank
114th
Iran rank
113th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Guatemala
- Iran
How they compare
Iran currently reports 54.9% against 54.7% in Guatemala, a difference of 0.2%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Iran ahead.
Guatemala ranks 114th and Iran ranks 113th of 185 countries.
Across the 3 decades both report, Guatemala averaged higher in 1 and Iran in 2.
Head to head by decade
| Decade | Guatemala | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.5% | 68.3% | 16.8% | Iran |
| 2010s | 66.6% | 74.0% | 7.4% | Iran |
| 2020s | 59.1% | 56.5% | 2.6% | Guatemala |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Guatemala or Iran?
- Iran, at 54.9% against 54.7% in Guatemala as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Guatemala and Iran?
- 0.2%, with Iran ahead.
- How many years of comparable data are there for Guatemala and Iran?
- 6 years are reported by both, from 2000 to 2021.
- How do Guatemala and Iran rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Guatemala ranks 114th and Iran ranks 113th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.